Neurovascular Devices Market by Device Type (Neurothrombectomy, Cerebral Angioplasty & Stenting Systems, Others), Therapeutic Application, Regions, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2019 to 2026

  • Publish Date: Jul, 2019
  • Report ID: 399156
  • Category: Healthcare
  • Pages: 250
$4700

Global neurovascular devices market is expected to reach USD 3.48 Billion by 2026, at a CAGR of 5.97% from 2019 to 2026. Growing preference for the minimally invasive surgeries, global increase in geriatric population and favorable medical reimbursement conditions are driving the global neurovascular devices market.

Market Overview:

Neurovascular devices are mainly used in the surgery, diagnosis and treatment of various neurological diseases. These devices are immensely used in the treatment and diagnosis of all categories of diseases and conditions involving the peripheral and central nervous system. Neurovascular devices aid in the treatment of various neurovascular disorders such as cerebral aneurysms and intracranial atherosclerotic disease. Thus, the rising incidence of the neurological disorders coupled with a growing demand for effective neurovascular devices are expected to drive the market growth over the forecast period.

Report Description:

  • The base year for the study has been considered 2018, historic year 2016 and 2017 and, the forecast period considered is from 2019 to 2026. The global neurovascular devices market is analysed on the basis of value (USD Billion) volume (Thousand Units), consumption (Thousand Units), imports (Thousand Units) and exports (Thousand Units).
  • The study delivers a comprehensive analysis of global neurovascular devices market by device type, therapeutic application and regions. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global neurovascular devices market. This report incorporates the industry analysis which is focused on providing an extensive view of the neurovascular devices market.
  • The study also includes attractiveness analysis of device type, therapeutic application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the neurovascular devices market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Global increase in geriatric population
  • Increasing prevalence of neurovascular disorders
  • Favorable medical reimbursements regulations
  • Growing market demand for effective neurovascular devices

Restrains:

  • Stringent regulatory approval process
  • Paucity of skilled neurosurgeons

Opportunities:

  • Increasing research activity in the field of neurovascular therapies
  • Growing preference for the minimally invasive neurosurgical procedures
  • Growing awareness among neurosurgeons about minimally invasive surgical procedures

Challenges:

  • High cost of the surgery

Global Neurovascular Devices Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment.

Segmentation Analysis:

The global Neurovascular Devices market has been segmented on the basis of device type, and therapeutic application.

  • Device type segment is divided into cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, and support devices. The cerebral embolization and aneurysm coiling devices segment led the global market with a 38.74% share of market revenue in 2018. This increased market share can be attributed to the large number of people undergoing neurological surgery as well as availability of these products in various lengths and volumes.
  • The therapeutic application segment includes stroke, cerebral artery stenosis, cerebral aneurysm, others. The cerebral aneurysm segment is anticipated to grow at an accelerated CAGR of 8.04% over the forecast period. Growing prevalence of the cerebral aneurysms along with its treatment with the help of embolizing coils and stents are expected to fuel this growth over the forecast period.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. The North America region emerged as the largest market for the neurovascular devices with a 42.18% share of market revenue in 2018.

  • Presence of well-developed healthcare facilities, high incidence rate of the neurological stroke along with favorable reimbursement structure and availability of advanced technologies with higher efficiency and reliability led the North America region to dominate the global demand for the neurovascular devices in 2018.
  • The Asia Pacific region is projected to grow at the highest CAGR of 8.24% over the forecast period. Growing awareness pertaining to neurovascular disorders and its management, rapid improvement in the standard of healthcare facilities are some of the factors that are expected to drive this increased growth rate. 

Global Neurovascular Devices Market Competitive Analysis:

Key players in the global neurovascular devices market are Abbott Laboratories, W. L. Gore & Associates, Inc., Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Stryker Corp., Terumo Medical Corporation, Integer Holdings Corporation, and Acandis GmbH & Co. KG among others. Major players are focusing on new product launch in order to effectively participate in the highly competitive market. For instance in 2016, Penumbra, Inc. launched ACE 68 Reperfusion Catheter for the treatment of acute ischemic stroke. It includes latest technological advancements to deliver maximum aspiration power for extracting thrombus in acute ischemic stroke patients.

*All our reports are customizable as per customer requirements

This study forecasts revenue and volume growth at global, regional, and country levels from 2016 to 2026. Fior Market Research has segmented the global neurovascular devices market on the basis of below mentioned segments:

Global Neurovascular Devices Market by Device Type:

  • Cerebral Embolization and Aneurysm Coiling Devices
  • Cerebral Angioplasty and Stenting Systems
  • Neurothrombectomy Devices
  • Support devices

Global Neurovascular Devices Market by Therapeutic Application:

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm
  • Others

Global Neurovascular Devices Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa         
    • UAE
    • South Africa
  1. INTRODUCTION
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. RESEARCH SCOPE
    4. CURRENCY
  2. RESEARCH METHODOLOGY AND ASSUMPTIONS
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. TOP INVESTMENT POCKETS
      1. MARKET ATTRACTIVENESS ANALYSIS BY DEVICE TYPE
      2. MARKET ATTRACTIVENESS ANALYSIS BY THERAPEUTIC APPLICATION
      3. MARKET ATTRACTIVENESS ANALYSIS BY REGION
    2. PORTER’S FIVE FORCES ANALYSIS
      1. THREAT OF NEW ENTRANTS
      2. THREAT OF SUBSTITUTES
      3. BARGAINING POWER OF SUPPLIERS
      4. BARGAINING POWER OF BUYERS
      5. INTENSITY OF COMPETITIVE RIVALRY
    3. PESTEL ANALYSIS
    4. INDUSTRY SWOT ANALYSIS
    5. INDUSTRY TRENDS
    6. MICRO AND MACRO FACTORS AFFECTING GLOBAL NEUROVASCULAR DEVICES MARKET
    7. PRICING ANALYSIS
      1. PRICING ASSUMPTIONS
      2. PRICE PROJECTIONS PER REGION
    8. MACRO-ECONOMIC FACTORS
      1. SUPPLY SIDE
      2. DEMAND SIDE
    9. TRADE MAP ANALYSIS (IMPORT-EXPORT DATA)
    10. COUNTRY LEVEL ANALYSIS
    11. PENETRATION & GROWTH PROSPECT MAPPING
    12. INDUSTRY VALUE CHAIN ANALYSIS
      1. RAW MATERIALS ANALYSIS
      2. SUPPLIER ANALYSIS
      3. END USER ANALYSIS
    13. CUSTOMERS/BUYERS BY REGIONS
  5. MARKET DYNAMICS
    1. MARKET EVALUATION
    2. DRIVERS
      1. GLOBAL INCREASE IN GERIATRIC POPULATION
      2. INCREASING PREVALENCE OF NEUROVASCULAR DISORDERS
      3. FAVORABLE MEDICAL REIMBURSEMENTS REGULATIONS
      4. GROWING MARKET DEMAND FOR EFFECTIVE NEUROVASCULAR DEVICES
    3. RESTRAINS
      1. STRINGENT REGULATORY APPROVAL PROCESS
      2. PAUCITY OF SKILLED NEUROSURGEONS
    4. OPPORTUNITIES
      1. INCREASING RESEARCH ACTIVITY IN THE FIELD OF NEUROVASCULAR THERAPIES
      2. GROWING PREFERENCE FOR THE MINIMALLY INVASIVE NEUROSURGICAL PROCEDURES
      3. GROWING AWARENESS AMONG NEUROSURGEONS ABOUT MINIMALLY INVASIVE SURGICAL PROCEDURES
    5. CHALLENGES
      1. HIGH COST OF THE SURGERY
  6. GLOBAL NEUROVASCULAR DEVICES MARKET ANALYSIS AND FORECAST, BY DEVICE TYPE
    1. SEGMENT OVERVIEW
    2. CEREBRAL EMBOLIZATION AND ANEURYSM COILING DEVICES
    3. CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS
    4. NEUROTHROMBECTOMY DEVICES
    5. SUPPORT DEVICES
  7. GLOBAL NEUROVASCULAR DEVICES MARKET ANALYSIS AND FORECAST, BY THERAPEUTIC APPLICATION
    1. SEGMENT OVERVIEW
    2. STROKE
    3. CEREBRAL ARTERY STENOSIS
    4. CEREBRAL ANEURYSM
    5. OTHERS
  8. GLOBAL NEUROVASCULAR DEVICES MARKET ANALYSIS AND FORECAST, BY REGIONAL ANALYSIS
    1. SEGMENT OVERVIEW
    2. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. GERMANY
      2. FRANCE
      3. U.K.
      4. ITALY
      5. SPAIN
      6. REST OF EUROPE
    4. ASIA-PACIFIC
      1. JAPAN
      2. CHINA
      3. INDIA
      4. REST OF APAC
    5. SOUTH AMERICA
      1. BRAZIL
      2. REST OF SA
    6. MIDDLE EAST AND AFRICA
      1. UAE
      2. SOUTH AFRICA
      3. REST OF MEA
  9. GLOBAL NEUROVASCULAR DEVICES MARKET-COMPETITIVE LANDSCAPE
    1. OVERVIEW
    2. MARKET SHARE OF KEY PLAYERS IN THE NEUROVASCULAR DEVICES MARKET
      1. GLOBAL COMPANY MARKET SHARE
      2. NORTH AMERICA COMPANY MARKET SHARE
      3. EUROPE COMPANY MARKET SHARE
      4. APAC COMPANY MARKET SHARE
    3. COMPETITIVE SITUATIONS AND TRENDS
      1. DEVICE TYPE LAUNCHES AND DEVELOPMENTS
      2. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
      3. MERGERS & ACQUISITIONS
      4. EXPANSIONS
  10. COMPANY PROFILES
    1. ABBOTT LABORATORIES
      1. BUSINESS OVERVIEW
      2. COMPANY SNAPSHOT
      3. KEY FINANCIAL
        1. REVENUE ANALYSIS
        2. PRICE ANALYSIS
        3. COST ANALYSIS
        4. VOLUME ANALYSIS
        5. MARGIN ANALYSIS
        6. COMPANY SEGMENT ANALYSIS
      4. COMPANY PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
      6. SWOT ANALYSIS
    2. W. L. GORE & ASSOCIATES, INC
    3. JOHNSON & JOHNSON
    4. MEDTRONIC PLC
    5. MERIT MEDICAL SYSTEMS, INC
    6. MICROPORT SCIENTIFIC CORPORATION
    7. PENUMBRA, INC
    8. STRYKER CORP
    9. TERUMO MEDICAL CORPORATION
    10. INTEGER HOLDINGS CORPORATION
    11. ACANDIS GMBH & CO. KG

LIST OF TABLE

  1. GLOBAL NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  2. GLOBAL CEREBRAL EMBOLIZATION AND ANEURYSM COILING NEUROVASCULAR DEVICES MARKET, REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  3. GLOBAL CEREBRAL ANGIOPLASTY AND STENTING SYSTEMS NEUROVASCULAR DEVICES MARKET, REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  4. GLOBAL NEUROTHROMBECTOMY NEUROVASCULAR DEVICES MARKET, REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  5. GLOBAL SUPPORT DEVICES NEUROVASCULAR DEVICES MARKET, REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  6. GLOBAL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  7. GLOBAL STROKE NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  8. GLOBAL CEREBRAL ARTERY STENOSIS NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  9. GLOBAL CEREBRAL ANEURYSM NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  10. GLOBAL OTHERS NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  11. GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  12. GLOBAL NEUROVASCULAR DEVICES MARKET, BY NORTH AMERICA, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  13. NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  14. NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  15. U.S. NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  16. U.S. NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  17. CANADA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  18. CANADA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  19. MEXICO NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  20. MEXICO NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  21. EUROPE NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  22. EUROPE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  23. GERMANY NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  24. GERMANY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  25. FRANCE NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  26. FRANCE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  27. U.K. NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  28. U.K. NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  29. ITALY NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  30. ITALY NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  31. SPAIN NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  32. SPAIN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  33. ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  34. ASIA PACIFIC NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  35. JAPAN NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  36. JAPAN NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  37. CHINA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  38. CHINA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  39. INDIA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  40. INDIA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  41. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  42. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  43. BRAZIL NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  44. BRAZIL NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  45. MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  46. MIDDLE EAST AND AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  47. UAE NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  48. UAE NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)
  49. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)  
  50. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (THOUSAND UNITS), PRICE (USD/UNIT)

LIST OF FIGURES 

  1. GLOBAL NEUROVASCULAR DEVICES  MARKET SEGMENTATION
  2. NEUROVASCULAR DEVICES  MARKET: RESEARCH METHODOLOGY
  3. MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  4. MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  5. DATA TRIANGULATION
  6. PORTER’S FIVE FORCES ANALYSIS
  7. VALUE CHAIN ANALYSIS
  8. GLOBAL NEUROVASCULAR DEVICES MARKET ATTRACTIVENESS ANALYSIS BY DEVICE TYPE
  9. GLOBAL NEUROVASCULAR DEVICES MARKET ATTRACTIVENESS ANALYSIS BY THERAPEUTIC APPLICATION
  10. GLOBAL NEUROVASCULAR DEVICES MARKET ATTRACTIVENESS ANALYSIS BY REGION
  11. GLOBAL NEUROVASCULAR DEVICES MARKET: DYNAMICS
  12. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE BY DEVICE TYPE (2018 & 2026)
  13. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE BY THERAPEUTIC APPLICATION (2018 & 2026)
  14. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE BY REGIONS (2018 & 2026)
  15. GLOBAL NEUROVASCULAR DEVICES MARKET SHARE BY COMPANY (2019)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


+1

Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.